ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

Why Advanced Solid Tumors Cancer is on this study

  • ClinicalTrials.gov filed the study under Advanced Solid Tumors Cancer; it no longer does.
  • Rule based: not read yet.
11 links0 made here, not in the record11 judgments1 judge (the rules as one: Rule based)1 record change seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07678593A Study of GFH276 CombinedWith Cetuximab orChemotherapy inParticipants With SolidTumors and PancreaticDuctal Adenocarcinoma(PDAC) Harboring RASGenfleet Therapeutics (ShanghaPhase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 5 · ClinicalTrials.gov record · Version of 2026-10-05Version of 2026-10-05CONDITIONSAdvanced Solid Tumors CancerNo longer in the registry's filing›Nov 14 · Rule based · Not readNot readPancreatic Ductal Adenocarc…No longer in the registry's filing›Nov 14 · Rule based · Not readNot readRAS MutationNo longer in the registry's filing›Nov 14 · Rule based · Not readNot readDRUGSGFH276Intervention entry›As of now · Rule based · BackgroundBackgroundCetuximabIntervention entry›As of now · Rule based · BackgroundBackgroundAlbumin-Bound PaclitaxelEntry “Nab paclitaxel”, read by our n…›As of now · Rule based · BackgroundBackgroundGemcitabineIntervention entry›As of now · Rule based · BackgroundBackgroundFluorouracilIntervention entry›As of now · Rule based · BackgroundBackgroundLeucovorinIntervention entry›As of now · Rule based · BackgroundBackgroundIrinotecanIntervention entry›As of now · Rule based · BackgroundBackgroundOxaliplatinIntervention entry›As of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
1 version of the record seen on ClinicalTrials.gov, Oct 5 · changes seen, not judgments
Nov 14Advanced Solid Tumors CancerRule based · condition-kind ruleNot readCurrent
Nov 14Pancreatic Ductal AdenocarcinomaRule based · condition-kind ruleNot readCurrent
Nov 14RAS MutationRule based · condition-kind ruleNot readCurrent
As of nowGFH276Rule based · role ruleBackgroundCurrent
As of nowCetuximabRule based · role ruleBackgroundCurrent
As of nowAlbumin-Bound PaclitaxelRule based · role ruleBackgroundCurrent
As of nowGemcitabineRule based · role ruleBackgroundCurrent
As of nowFluorouracilRule based · role ruleBackgroundCurrent
As of nowLeucovorinRule based · role ruleBackgroundCurrent
As of nowIrinotecanRule based · role ruleBackgroundCurrent
As of nowOxaliplatinRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.